| Trademark Snap Shot ITU Unit Action (Table presents the data on ITU Unit Action) |
|||
OVERVIEW |
|||
| SERIAL NUMBER | 88350607 | FILING DATE | 03/21/2019 |
| REG NUMBER | 0000000 | REG DATE | N/A |
| REGISTER | PRINCIPAL | MARK TYPE | TRADEMARK |
| INTL REG # | N/A | INTL REG DATE | N/A |
| TM ATTORNEY | RINGLE, JAMES W |
L.O. ASSIGNED | 111 |
PUB INFORMATION |
|||
| RUN DATE | 12/08/2020 | ||
| PUB DATE | 06/04/2019 | ||
| STATUS | 732-THIRD EXTENSION - GRANTED | ||
| STATUS DATE | 12/04/2020 | ||
| LITERAL MARK ELEMENT | AQZELO | ||
| DATE ABANDONED | N/A | DATE CANCELLED | N/A |
| SECTION 2F | NO | SECTION 2F IN PART | NO |
| SECTION 8 | NO | SECTION 8 IN PART | NO |
| SECTION 15 | NO | REPUB 12C | N/A |
| RENEWAL FILED | NO | RENEWAL DATE | N/A |
| DATE AMEND REG | N/A | ||
FILING BASIS |
|||||
| FILED BASIS | CURRENT BASIS | AMENDED BASIS | |||
| 1 (a) | NO | 1 (a) | NO | 1 (a) | NO |
| 1 (b) | YES | 1 (b) | YES | 1 (b) | NO |
| 44D | NO | 44D | NO | 44D | NO |
| 44E | NO | 44E | NO | 44E | NO |
| 66A | NO | 66A | NO | ||
| NO BASIS | NO | NO BASIS | NO | ||
MARK DATA |
|
| STANDARD CHARACTER MARK | YES |
| LITERAL MARK ELEMENT | AQZELO |
| MARK DRAWING CODE | 4-STANDARD CHARACTER MARK |
| COLOR DRAWING FLAG | NO |
CURRENT OWNER INFORMATION |
|
| PARTY TYPE | 20-OWNER AT PUBLICATION |
| NAME | Eli Lilly and Company |
| ADDRESS | Lilly Corporate Center Indianapolis, IN 46285 |
| ENTITY | 03-CORPORATION |
| CITIZENSHIP | Indiana |
GOODS AND SERVICES |
|
| INTERNATIONAL CLASS | 005 |
| DESCRIPTION TEXT | Pharmaceutical preparations namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, neurodegenerative diseases and disorders, neurological disorders, obesity, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases and of oncology and of pain |
GOODS AND SERVICES CLASSIFICATION |
|||||||
| INTERNATIONAL CLASS | 005 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
MISCELLANEOUS INFORMATION/STATEMENTS |
|
| CHANGE IN REGISTRATION | NO |
| TRANSLATION | The wording "AQZELO" has no meaning in a foreign language. |
PROSECUTION HISTORY |
||||
| DATE | ENT CD | ENT TYPE | DESCRIPTION | ENT NUM |
| 12/08/2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 021 |
| 12/04/2020 | EX3G | S | EXTENSION 3 GRANTED | 020 |
| 12/04/2020 | EXT3 | S | EXTENSION 3 FILED | 019 |
| 12/04/2020 | EEXT | I | TEAS EXTENSION RECEIVED | 018 |
| 06/25/2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 017 |
| 06/24/2020 | EX2G | S | EXTENSION 2 GRANTED | 016 |
| 06/08/2020 | EXT2 | S | EXTENSION 2 FILED | 015 |
| 06/24/2020 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | 014 |
| 06/08/2020 | EEXT | I | TEAS EXTENSION RECEIVED | 013 |
| 12/13/2019 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 012 |
| 12/11/2019 | EX1G | S | EXTENSION 1 GRANTED | 011 |
| 12/11/2019 | EXT1 | S | EXTENSION 1 FILED | 010 |
| 12/11/2019 | EEXT | I | TEAS EXTENSION RECEIVED | 009 |
| 07/30/2019 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 008 |
| 06/04/2019 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 007 |
| 06/04/2019 | PUBO | A | PUBLISHED FOR OPPOSITION | 006 |
| 05/15/2019 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 005 |
| 04/24/2019 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | 004 |
| 04/16/2019 | DOCK | D | ASSIGNED TO EXAMINER | 003 |
| 04/08/2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 002 |
| 03/25/2019 | NWAP | I | NEW APPLICATION ENTERED IN TRAM | 001 |
CURRENT CORRESPONDENCE INFORMATION |
|
| ATTORNEY | Bruce W. Longbottom |
| CORRESPONDENCE ADDRESS | Bruce W. Longbottom ELI LILLY AND COMPANY LILLY CORPORATE CENTER INDIANAPOLIS IN 46285 |
| DOMESTIC REPRESENTATIVE | NONE |
PRIOR OWNER INFORMATION |
|
| PARTY TYPE | 10-ORIGINAL APPLICANT |
| NAME | Eli Lilly and Company |
| ADDRESS | Lilly Corporate Center Indianapolis, IN 46285 |
| ENTITY | 03-CORPORATION |
| CITIZENSHIP | Indiana |